Wire flash
Tonghe Pharmaceutical's controlling shareholder Pang Zhengwei plans to buy up to 15 million yuan of shares
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
Tonghe Pharmaceutical announced that its controlling shareholder and one of its actual controllers, Pang Zhengwei, plans to increase his stake in the company. The planned share purchase will be conducted through centralized竞价, block trading, or other methods permitted by laws and regulations. The total amount of the share purchase is set to be no less than 10 million yuan and no more than 15 million yuan. The plan is scheduled to be implemented within six months from the date of the announcement.
Source report
Shanghai — Tonghe Pharmaceutical Co., Ltd. has announced that Pang Zhengwei, one of the company's controlling shareholders and actual controllers, plans to increase his shareholding in the company.
The share increase will be carried out through centralized竞价 trading, block trading, or other methods permitted by laws and regulations. The total amount of the share increase is expected to be no less than RMB 10 million and no more than RMB 15 million.
The plan is scheduled to be implemented within six months from the date of this announcement.
Source
证券之星-股市直击Neutral / independent
Part of this Story
Tonghe Pharmaceutical Chairman Pang Zhengwei Plans 10-15 Million Yuan Share Purchase